You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
人民日報:醫藥領域學術會議陸續恢復 正常學術會議是行業必須
醫藥研發外包概念股(CRO)今早股價上揚,藥明生物(02269.HK)股價走高近5.5%,藥明康德(02359.HK)揚4.3%,金斯瑞生物科技(01548.HK)走高4.1%,康龍化成(03759.HK)漲5.7%。 據《人民日報》健康客戶端報道,9月以來,內地醫藥領域的學術會議陸續恢復,不少學術會議通知恢復召開。據不完全統計,9月至少要舉辦9場醫藥行業學術會議、論壇等。此外,還有部分會議近期持續宣布召開。 北京市鑫諾律師事務所高級合夥人展曙光表示,醫藥學術會議是這個行業非常正常的一部分構成,交流經驗、探討問題也是行業內正常發展中必不可少的。 而中國國際旅行衛生保健協會醫療物資與醫療合作分會秘書長陳紅彥表示,正常學術會議的恢復有助於行業重新回歸正軌。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account